TAURX PHARMACEUTICALS
TauRx Therapeutics Ltd was established in Singapore in 2002 with the aim of developing new treatments and diagnostics for a range of neurodegenerative diseases based on an entirely new approach which targets aggregates of abnormal fibres of Tau protein that form inside nerve cells in the brain. The TauRx team have since discovered that LMTX™ could also have beneficial effects in several other neurodegenerative diseases associated with Tau pathology, as well as other protein aggregation disorders including Parkinson’s, Huntington’s and Frontotemporal Dementia (Pick’s Disease). While TauRx headquarters are in Singapore, its primary research facilities are in Aberdeen, Scotland.
TAURX PHARMACEUTICALS
Industry:
Biotechnology Health Diagnostics Pharmaceutical
Founded:
2002-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.taurx.com
Total Employee:
501+
Status:
Active
Total Funding:
376.5 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Apple Mobile Web Clips Icon Google Tag Manager Google Analytics Content Delivery Network LetsEncrypt SSL By Default
Similar Organizations
Advanced Animal Diagnostics
Advanced Animal Diagnostics develops diagnostic products to cure on-farm animal diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Idenix Pharmaceuticals
Idenix Pharmaceuticals is focused on the discovery and development of drugs for the treatment of human viral diseases.
Kira Pharmaceuticals
Kira Pharmaceuticals is a Biotechnology Research Company.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Wave Life Sciences
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Zhiyi Pharmaceutics
Zhiyi Pharmaceutics focuses on the research and development of second-generation probiotics and Live Biotherapeutics.
Current Advisors List
Advisor
Board_member
Advisor
Board_member
Board_member
Advisor
Advisor
Advisor
Current Employees Featured
Tim Earle Chief Business Officer (Aberdeen) @ TauRx Pharmaceuticals
Chief Business Officer (Aberdeen)
2012-01-01
John K S Cheung Chief Development Officer (Aberdeen) @ TauRx Pharmaceuticals
Chief Development Officer (Aberdeen)
2004-01-01
Jiri Hardlund Chief Medical Officer (Aberdeen) @ TauRx Pharmaceuticals
Chief Medical Officer (Aberdeen)
2012-01-01
Charles Harrington Chief Scientific Officer (Aberdeen) @ TauRx Pharmaceuticals
Chief Scientific Officer (Aberdeen)
Claude Wischik Co-Founder, Chairman and Chief Executive (Aberdeen) @ TauRx Pharmaceuticals
Co-Founder, Chairman and Chief Executive (Aberdeen)
John Storey Technical Head (Aberdeen) @ TauRx Pharmaceuticals
Technical Head (Aberdeen)
Diane Downie Global Logistics and Support Lead (Aberdeen) @ TauRx Pharmaceuticals
Global Logistics and Support Lead (Aberdeen)
2004-01-01
Hwang Hong Wei Finance Director (Singapore) @ TauRx Pharmaceuticals
Finance Director (Singapore)
2010-01-01
Rebecca Andersen Head Of Commercial and Communications @ TauRx Pharmaceuticals
Head Of Commercial and Communications
2022-03-01
Goh Lee Sian Alternate Director @ TauRx Pharmaceuticals
Alternate Director
Founder
Investors List
Arcane Group
Arcane Group investment in Private Equity Round - TauRx Pharmaceuticals
Dundee Corporation
Dundee Corporation investment in Private Equity Round - TauRx Pharmaceuticals
Genting management
Genting management investment in Venture Round - TauRx Pharmaceuticals
Official Site Inspections
http://www.taurx.com Semrush global rank: 4.67 M Semrush visits lastest month: 2.02 K
- Host name: ns10.webint.co.uk
- IP address: 139.162.244.96
- Location: London United Kingdom
- Latitude: 51.5164
- Longitude: -0.093
- Timezone: Europe/London
- Postal: EC2V
More informations about "TauRx Pharmaceuticals"
About Us - TauRx Pharmaceuticals
TauRx is a leader in the research and study of Alzheimer's disease and other neurodegenerative conditions. About Us Home • About Us; We are dedicated to research in neurodegenerative …See details»
Pioneering a treatment for Alzheimer’s …
For decades, Professor Claude Wischik, co-founder and CEO of TauRx, has led a scientific research team dedicated to finding an effective treatment for neurodegenerative diseases. Clinical …See details»
TauRx Therapeutics - Wikipedia
TauRx Therapeutics Ltd is a life sciences/pharmaceutical company incorporated in Singapore with primary research facilities and operations in Aberdeen, Scotland. The company was co-founded in 2002 by the late gynecologist, surgeon and venture capitalist K. M. Seng and Claude Wischik, Professor of Old Age Psychiatry at the University of Aberdeen, Scotland, who is currently the company's Executive Chairman. See details»
TauRx Pharmaceuticals - Crunchbase Company Profile …
TauRx Therapeutics Ltd was established in Singapore in 2002 with the aim of developing new treatments and diagnostics for a range of neurodegenerative diseases based on an entirely new approach which targets aggregates of …See details»
About TauRx Pharmaceuticals - pharmiweb.jobs
Jan 30, 2024 TauRx was founded in 2002 in Singapore, with primary research facilities and operation based in Aberdeen, UK. The company has dedicated the past two decades to developing treatments and diagnostics for Alzheimer’s …See details»
TauRx Pharmaceuticals - VentureRadar
A leader in Alzheimer’s disease research, TauRx’s mission is to discover, develop and commercialise innovative products for the diagnosis, treatment and cure of neurodegenerative …See details»
TauRx Pharmaceuticals Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore TauRx Pharmaceuticals Ltd. with its drug pipeline, therapeutic area, technology platform, 14 news, and 1 literature, Disease Domain:Nervous System Diseases, Endocrinology and …See details»
TauRx - Company Profile - Tracxn
Jan 5, 2025 TauRx is a developer of drugs and diagnostic compounds for Alzheimer's disease (AD), frontotemporal dementia (FTD), and other neurodegenerative diseases. The company’s …See details»
TauRx Pharmaceuticals - Contacts, Employees, Board Members
TauRx Pharmaceuticals has 15 board members and advisors, including Howard Feldman. Contacts. Edit Contacts Section. Job Department. Protected Content. Chief Operating Officer …See details»
History of TauRx - TauRx - TauRx Pharmaceuticals
Co-founder and CEO of TauRx, Professor Claude Wischik, is a board-certified psychiatrist and Chair of Mental Health at the University of Aberdeen. For 30 years, he has led a scientific …See details»
TauRx - LinkedIn
TauRx was established to address one of the world’s biggest challenges – beating Alzheimer’s disease and other degenerative brain disorders through a completely new approach.See details»
Dundee Corporation Portfolio Holding, TauRx Pharmaceuticals Ltd ...
TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) — Dundee Corporation (TSX: DC.A) (the “Corporation” or “Dundee”) today announces that TauRx Pharmaceuticals Ltd. (“TauRx”), a …See details»
TauRx Company Profile - Office Locations, Competitors, Revenue
TauRx has 5 employees across 3 locations and $10.5 m in total funding,. See insights on TauRx including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
TauRx sees path to FDA filing for tau-targeting Alzheimer's drug
1 day ago TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company …See details»
Dundee Corporation Portfolio Holding, TauRx Pharmaceuticals Ltd ...
Oct 6, 2022 Dundee holds 1,015,008 shares in TauRx, representing an undiluted interest of 3.5% in the company (3.2% fully diluted, with warrants exercisable over a four-week period …See details»
Alzheimer’s Disease Next Game Changer: TauRx Pharmaceutical’s …
Aug 28, 2024 The advancements in medicine, public health and living standards in recent decades have significantly increased the global life expectancy by more than six years — from …See details»
Mission and values - TauRx Pharmaceuticals
For decades, Professor Claude Wischik, co-founder and CEO of TauRx, has led a scientific research team dedicated to finding an effective treatment for neurodegenerative diseases. …See details»
TauRx Pharmaceuticals - Funding, Financials, Valuation & Investors
TauRx Pharmaceuticals is a life sciences company developing drugs and diagnostics for neurodegenerative diseases. Search Crunchbase. Start Free Trial . ... How much funding has …See details»
George Medicines signs exclusive licensing agreement with
1 day ago George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia and Central America Bausch...See details»
News and Insights - TauRx - TauRx Pharmaceuticals
News. Browse our news to stay up to date with our progress and milestones. These articles provide a broad overview of our ongoing efforts to advance a treatment for neurodegenerative …See details»